Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis

References

• Hetta W. Role of diffusion weighted images combined with breast MRI in improving the detection and differentiation of breast lesions. Egyptian J Radiol Nuclear Med. 2015;46(1):259–270.
   Google Scholar
• Rudolph A, Chang-Claude J, Schmidt MK. Gene–environment interaction and risk of breast cancer. Br J Cancer. 2016;114(2):125–133.
   PubMed Web of Science ®Google Scholar
• Yue Z, Li HT, Yang Y, et al. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information. Oncotarget. 2016;7(24):36092–36100.
   PubMedGoogle Scholar
• McDonald ES, Clark AS, Tchou J, et al. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Supplement_1):9s–16s.
   PubMed Web of Science ®Google Scholar
• Roder D, Farshid G, Kollias J, et al. Female breast cancer management and survival: the experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly. 2017;23(6):1433–1443.
   Google Scholar
• Chen Y, Jing W, Wang X, et al. STAT3, a poor survival predicator, is associated with lymph node metastasis from breast cancer. J Breast Cancer. 2013;16(1):40.
   PubMed Web of Science ®Google Scholar
• Qi FU, Shi L, Yang GW, et al. Influencing factors of recurrence and metastasis for postoperative breast cancer high-risk population and evaluation on TCM therapy. Chinese J Inf Trad Chinese Med. 2014;21(2):27–31.
   Google Scholar
• Lei Y. Influence analysis of clinical nursing on the incidence of postoperative complications in total pneumonectomy for lung cancer. China Med Pharm. 2015;5(5):118–120.
   Google Scholar
• Yan Z, Lai Z, Lin J. Anticancer properties of traditional Chinese medicine. Comb Chem High Throughput Screen. 2017;20(5):423–429.
   PubMed Web of Science ®Google Scholar
• Tao F, Ruan S, Liu W, et al. Fuling granule, a traditional Chinese medicine compound, suppresses cell proliferation and TGFβ-induced EMT in ovarian cancer. Plos One. 2016;11(12):e0168892.
   PubMed Web of Science ®Google Scholar
• Chen B, Zhang Y, Wang Y, et al. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J Steroid Biochem Mol Biol. 2014;143:11–18.
   PubMed Web of Science ®Google Scholar
• Liang Y, Xu X, Yu H, et al. Raddeanoside R13 inhibits breast cancer cell proliferation, invasion, and metastasis. Tumor Biol. 2016;37(7):9837–9847.
   PubMedGoogle Scholar
• Zhou B, Lu X, Tang Z, et al. Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis. Biomed Pharmacother. 2017;90:835–841.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang R, Jiang C, et al. Synthesis and anti-inflammatory effect of sinomenine 4-hydroxy esters. Chem Nat Compd. 2018;54(1):131–136.
   Web of Science ®Google Scholar
• Sun YH, Zhu Q, Jun-Xu LI, et al. Research progress on anti-inflammatory and anti-tumor effects of sinomenine. Chinese Pharmacol Bull. 2015;31(8):1040–1043.
   Google Scholar
• Yang H, Shi Z, Ma Y. Effect of sinomenine on cell proliferation and cell cycle in human colon cancer SW480 cells. J Med Res. 2014;43(7):72–75.
   Google Scholar
• Fan J, Wang JC, Chen Y, et al. Sinomenine induces apoptosis of prostate cancer cells by blocking activation of NF-kappa B. African J Biotechnol. 2011;10(17):3480–3487.
   Google Scholar
• Lv Y, Li C, Li S, et al. Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression. Oncol Lett. 2011;2(4):741–745.
   PubMed Web of Science ®Google Scholar
• Jiang S, Gao Y, Wei H, et al. Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncol Lett. 2016;12(2):1380.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Gu B, Ji X, et al. Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalolmyelitis. Biol Pharm Bull. 2007;30(8):1438–1444.
   PubMed Web of Science ®Google Scholar
• Zhou L, Luan H, Liu Q, et al. Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis. Mol Med Rep. 2012;5(5):1256–1260.
   PubMed Web of Science ®Google Scholar
• Li X, Wang K, Ren Y, et al. MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study. Cell Death Dis. 2014;5(7):e1356.
   PubMed Web of Science ®Google Scholar
• Song L, Liu D, Zhao Y, et al. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-kappaB activation mediated by IL-4/miR-324-5p/CUEDC2 axis. Biochem Biophys Res Commun. 2015;464(3):705–710.
   PubMed Web of Science ®Google Scholar
• Song L, Liu D, Zhao Y, et al. Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHh pathway. Biomed Pharmacother. 2018;98:687–693.
   PubMed Web of Science ®Google Scholar
• O'Bryan S, Dong S, Mathis JM, et al. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer. Eur J Cancer. 2017;72:1–11.
   PubMed Web of Science ®Google Scholar
• Takahashi RU, Miyazaki H, Ochiya T. The roles of MicroRNAs in breast cancer. Cancers (Basel). 2015;7(2):598.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang G, Wu JH, et al. Diverse roles of miR-29 in cancer (review). Oncol Rep. 2014;31(4):1509–1516.
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang X, Huang X, et al. The inhibitory role of Mir-29 in growth of breast cancer cells. J Exp Clin Cancer Res. 2013;32(1):98.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang J, Sun X, et al. Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer. Oncotarget. 2017;8(24):39559–39570.
   PubMedGoogle Scholar
• Cao CM, Sun ZX. Proceedings on the expression of tumor suppressor gene Pdcd4 and ubiquitin pathway of Pdcd4 protein: proceedings on the expression of tumor suppressor gene Pdcd4 and ubiquitin pathway of Pdcd4 protein. Prog Biochem Biophys. 2010;37(4):353–357.
   Web of Science ®Google Scholar
• Chen Z, Yuan YC, Wang Y, et al. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2015;152(1):29–39.
   PubMed Web of Science ®Google Scholar
• Gonzalezvillasana V, Gonzalezvillasana V, Nievesalicea R, et al. Programmed Cell Death 4 (PDCD4), a novel inhibitor of leptin-induced breast cancer cell invasion. Cancer Res. 2009;69(24 Supplement):6153–6153.
   Web of Science ®Google Scholar
• Huang J, Liu Q, Mo YY. Abstract 4142: Differential expression of PDCD4 in response to Resveratrol in breast cancer cells. Cancer Res. 2012;72(8 Supplement):4142–4142.
   Google Scholar
• Wen YY, Yang ZQ, Song M, et al. SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells. Cancer Sci. 2010;101(1):73–79.
   PubMed Web of Science ®Google Scholar
• Fenton MS, Marion KM, Salem AK, et al. Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer. Thyroid. 2010;20(9):965–974.
   PubMed Web of Science ®Google Scholar